Home › Therapeutic areas › Respiratory › Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (4 companies)
Companies with an active program in Idiopathic Pulmonary Fibrosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AGMB | Agomab Therapeutics | ImmunologyRespiratory Rare | 1 | Phase 2 | 4 |
| RVPH | Reviva Pharmaceuticals | CardiovascularDermatology+2 Rare | 1 | Phase 3 | 10 |
| SRPT | Sarepta Therapeutics | NeurologyRespiratory Rare | 1 | Approved | 10 |
| GPCR | Structure Therapeutics | MetabolicRespiratory Rare | 1 | Phase 3 | 5 |
No companies match.